Antibiotic Prescribing Patterns in Ghana, Uganda, Zambia and Tanzania Hospitals: Results from the Global Point Prevalence Survey (G-PPS) on Antimicrobial Use and Stewardship Interventions Implemented.
antibiotics
antimicrobial resistance
antimicrobial stewardship
antimicrobial surveillance
antimicrobials
global-pps
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
17 Sep 2021
17 Sep 2021
Historique:
received:
24
07
2021
revised:
03
09
2021
accepted:
13
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) remains an important global public health issue with antimicrobial misuse and overuse being one of the main drivers. The Global Point Prevalence Survey (G-PPS) of Antimicrobial Consumption and Resistance assesses the prevalence and the quality of antimicrobial prescriptions across hospitals globally. G-PPS was carried out at 17 hospitals across Ghana, Uganda, Zambia and Tanzania. The overall prevalence of antimicrobial use was 50% (30-57%), with most antibiotics prescribed belonging to the WHO 'Access' and 'Watch' categories. No 'Reserve' category of antibiotics was prescribed across the study sites while antimicrobials belonging to the 'Not Recommended' group were prescribed infrequently. Antimicrobials were most often prescribed for prophylaxis for obstetric or gynaecological surgery, making up between 12 and 18% of total prescriptions across all countries. The most prescribed therapeutic subgroup of antimicrobials was 'Antibacterials for systemic use'. As a result of the programme, PPS data are now readily available for the first time in the hospitals, strengthening the global commitment to improved antimicrobial surveillance. Antimicrobial stewardship interventions developed included the formation of AMS committees, the provision of training and the preparation of new AMS guidelines. Other common interventions included the presentation of findings to clinicians for increased awareness, and the promotion of a multi-disciplinary approach to successful AMS programmes. Repeat PPS would be necessary to continually monitor the impact of interventions implemented. Broader participation is also encouraged to strengthen the evidence base.
Identifiants
pubmed: 34572704
pii: antibiotics10091122
doi: 10.3390/antibiotics10091122
pmc: PMC8469030
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fleming Fund - CwPAMS project
ID : 00000
Références
BMC Public Health. 2019 Jun 21;19(1):797
pubmed: 31226974
Clin Infect Dis. 2010 Jan 1;50 Suppl 1:S16-23
pubmed: 20067388
Lancet Glob Health. 2019 Jul;7(7):e861-e871
pubmed: 31200888
Antimicrob Agents Chemother. 2007 Mar;51(3):864-7
pubmed: 17210766
J Matern Fetal Neonatal Med. 2008 Sep;21(9):638-42
pubmed: 18828055
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Am J Med. 2006 Jun;119(6 Suppl 1):S20-8; discussion S62-70
pubmed: 16735147
BMJ Open. 2020 Dec 15;10(12):e042819
pubmed: 33323448
Antimicrob Resist Infect Control. 2020 Sep 7;9(1):149
pubmed: 32894182
Bull World Health Organ. 2020 Mar 1;98(3):177-187C
pubmed: 32132752
Int J Infect Dis. 2020 Oct;99:10-18
pubmed: 32781162
JAC Antimicrob Resist. 2019 Nov 12;1(3):dlz072
pubmed: 34222945
BMC Infect Dis. 2004 Dec 15;4(1):59
pubmed: 15601475
Injury. 2011 Dec;42 Suppl 5:S3-6
pubmed: 22196908
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
J Antimicrob Chemother. 2001 Oct;48(4):463-78
pubmed: 11581224
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
Microbiol Spectr. 2018 Mar;6(2):
pubmed: 29600770
Antibiotics (Basel). 2014 Sep 10;3(3):450-60
pubmed: 27025755
J Antimicrob Chemother. 2021 May 12;76(6):1614-1624
pubmed: 33822971
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
JAC Antimicrob Resist. 2020 Feb 18;2(1):dlaa001
pubmed: 34222959
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Antibiotics (Basel). 2020 Aug 09;9(8):
pubmed: 32784880
Trop Med Int Health. 2015 Dec;20(12):1696-706
pubmed: 26311240
Antimicrob Resist Infect Control. 2018 Jan 26;7:15
pubmed: 29423190
Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-293
pubmed: 30755077
J Antimicrob Chemother. 2015 Apr;70(4):1245-55
pubmed: 25527272